NCT02137330View on ClinicalTrials.gov

Obalon in Children With Severe Obesity

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2014

Conditions
Severe Pediatric Obesity (BMI > 97° pc -According to Centers for Disease Control and Prevention BMI Charts-)Altered Liver Function TestsGlycemic Intolerance
Interventions
DEVICE

Swallowable Obalon® Gastric Balloon

Trial Locations (1)

00100

Bambino Gesù Children Hospital, Rome

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER

NCT02137330 - Obalon in Children With Severe Obesity | Biotech Hunter | Biotech Hunter